Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.47%23.83B | -15.98%17.46B | 0.79%5.45B | -31.02%4.01B | -26.68%3.86B | -3.61%4.14B | -11.94%20.78B | -12.94%5.41B | -5.68%5.81B | -18.13%5.27B |
| Cost of revenue | 17.62%14.37B | -8.78%12.22B | -0.40%3.52B | -18.30%2.96B | -13.72%2.99B | -0.86%2.76B | -8.44%13.39B | -18.00%3.53B | -9.40%3.62B | -5.10%3.46B |
| Gross profit | 80.39%9.46B | -29.03%5.24B | 2.98%1.94B | -52.13%1.05B | -51.46%878M | -8.60%1.38B | -17.65%7.39B | -1.42%1.88B | 1.16%2.19B | -35.14%1.81B |
| Operating expense | 11.44%4.87B | 4.55%4.37B | 2.55%1.09B | 0.48%1.05B | 3.62%1.12B | 11.86%1.12B | 4.08%4.18B | -7.59%1.06B | 6.12%1.04B | 16.94%1.08B |
| Staff costs | 18.39%1.25B | 13.20%1.06B | 40.09%325M | 4.18%249M | 3.88%241M | 4.80%240M | -14.18%932M | -33.52%232M | -5.91%239M | -10.42%232M |
| Research and development costs | -5.88%1.54B | 9.08%1.63B | -20.76%313M | 7.30%382M | 22.96%482M | 28.73%457M | 5.94%1.5B | 11.90%395M | 2.59%356M | 19.51%392M |
| Depreciation and amortization | 84.21%105M | 11.76%57M | ---- | ---- | ---- | ---- | 13.33%51M | ---- | ---- | ---- |
| -Depreciation | 84.21%105M | 11.76%57M | ---- | ---- | ---- | ---- | 13.33%51M | ---- | ---- | ---- |
| Other operating expenses | 21.80%1.98B | -4.41%1.62B | 2.62%392M | -6.97%414M | -13.25%393M | 1.43%425M | 15.50%1.7B | -4.50%382M | 17.41%445M | 35.63%453M |
| Operating profit | 425.54%4.59B | -72.79%873M | 3.54%849M | -99.83%2M | -132.51%-238M | -48.92%260M | -35.26%3.21B | 7.89%820M | -2.96%1.15B | -60.81%732M |
| Net non-operating interest income (expenses) | 117.65%3M | -6.25%-17M | -650.00%-15M | 25.00%-3M | 116.67%1M | 0 | 56.76%-16M | 50.00%-2M | 66.67%-4M | 14.29%-6M |
| Non-operating interest income | 56.00%39M | 177.78%25M | 166.67%8M | 150.00%5M | 250.00%7M | 150.00%5M | -10.00%9M | -25.00%3M | 0.00%2M | 0.00%2M |
| Non-operating interest expense | 33.33%36M | 8.00%27M | 60.00%8M | 33.33%8M | -25.00%6M | -16.67%5M | -16.67%25M | -28.57%5M | -25.00%6M | 14.29%8M |
| Total other finance cost | ---- | --15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -65.12%30M | -27.73%86M | 281.48%49M | 53.47%-67M | -80.16%25M | -51.83%79M | -19.59%119M | -137.50%-27M | -489.19%-144M | 1,045.45%126M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -53M | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1,750.00%33M | -101.65%-2M | 0 | 0 | 4,133.33%121M | 0.00%-1M | -4M | 0 | ||
| Less:Other special charges | -1,750.00%-33M | 101.65%2M | --0 | ---- | ---- | ---- | -4,133.33%-121M | 0.00%1M | --4M | --0 |
| Other non-operating income (expenses) | -60.87%27M | 115.63%69M | 290.91%43M | 0 | 1,300.00%24M | -77.78%2M | 6.67%32M | 57.14%11M | 75.00%14M | -125.00%-2M |
| Income before tax | 359.48%4.63B | -70.94%1.01B | 15.21%924M | -106.96%-70M | -121.90%-187M | -57.66%340M | -31.95%3.47B | -3.72%802M | -17.20%1.01B | -54.57%854M |
| Income tax | 205.21%1.17B | -54.98%384M | 657.14%273M | -86.85%43M | -116.54%-45M | -62.71%113M | -33.88%853M | -390.00%-49M | -18.66%327M | -51.08%272M |
| Net income | 455.31%3.45B | -76.19%622M | -23.71%650M | -116.52%-112M | -124.40%-142M | -54.80%226M | -31.30%2.61B | 0.95%852M | -16.61%678M | -56.04%582M |
| Net income continuous operations | 454.57%3.46B | -76.15%623M | -23.50%651M | -116.64%-113M | -124.40%-142M | -54.60%227M | -31.30%2.61B | 0.95%851M | -16.48%679M | -56.04%582M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 455.31%3.45B | -76.19%622M | -23.71%650M | -116.52%-112M | -124.40%-142M | -54.80%226M | -31.30%2.61B | 0.95%852M | -16.61%678M | -56.04%582M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 455.31%3.45B | -76.19%622M | -23.71%650M | -116.52%-112M | -124.40%-142M | -54.80%226M | -31.30%2.61B | 0.95%852M | -16.61%678M | -56.04%582M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 454.60%273.53 | -76.20%49.32 | -23.64%51.55 | -116.60%-8.94 | -124.38%-11.25 | -54.81%17.96 | -33.40%207.25 | 1.29%67.51 | -18.21%53.85 | -58.03%46.15 |
| Diluted earnings per share | 454.60%273.53 | -76.20%49.32 | -23.76%51.4685 | -116.63%-8.94 | -124.38%-11.25 | -54.81%17.96 | -33.39%207.25 | 1.29%67.51 | -18.33%53.7687 | -57.91%46.15 |
| Dividend per share | 62.50%65 | 0.00%40 | 0.00%20 | 0 | 0.00%20 | 0 | 0.00%40 | 0.00%20 | 0 | 0.00%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |